BOSTON, Dec 13 (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.


30


Reuters

Latest News

Daily Mail: Barcelona and PSG legend Ronaldinho retires from football

CTV News: Medical marijuana distributer plants roots near Regina

NewYorkTimes: Pentagon Suggests Countering Devastating Cyberattacks With Nuclear Arms

USA Today: Don’t say you weren’t warned about bitcoin

FOX: Anarchist college group calls for 'Law Enforcement Incineration Day'

Daily Mail: Peak hour chaos as a car becomes wedged between two trucks

CNN: Trump hotels swarmed with 's***hole' reviews on Yelp

Daily Mail: Marseille move up to second as Monaco held by Nice

Daily Mail: Predators place F Arvidsson on IR

CBC: Federal gov't removes poster after online backlash for Indigenous stereotypes

Reuters: Trump is sharp, but needs to lose weight: White House doctor

Reuters: Trump is sharp, but needs to lose weight: White House doctor

Reuters: Top Walmart executive to be appointed International CEO: source

WashingtonPost: Behold, the horde of fake Twitter accounts posing as the $450 million jackpot winner

FOX: Sen. Jeff Flake's big audition for the Trump-despising media

BBC: Minister for loneliness appointed to continue Jo Cox's work

BBC: West Ham United 1-0 Shrewsbury Town

ABC: The Latest: Neighbors didn't know about captive children

ABC: Mathilde Krim, AIDS research pioneer, dies at 91

ABC: CSX 4Q profit up 25 percent and railroad gets tax-cut boost

Daily Mail: Girlfriend wore wire to catch scholar's accused killer

Daily Mail: Ronan Keating and his wife Storm attend Geneva bash

CNBC: See how your mental fitness compares to that of self proclaimed 'stable genius' Donald Trump